Lexicon Pharmaceuticals LXRX Lease Liability Payments - Remainder of Fiscal Year
Lease Liability Payments - Remainder of Fiscal Year at other companies
Other financials
Where this comes from
Reported directly by Lexicon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's lease liability payments - remainder of fiscal year.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's lease liability payments - remainder of fiscal year?
- Lexicon Pharmaceuticals (LXRX) reported lease liability payments - remainder of fiscal year of $1.22M in Q1 2026.
- How has Lexicon Pharmaceuticals's lease liability payments - remainder of fiscal year changed year-over-year?
- Lexicon Pharmaceuticals's lease liability payments - remainder of fiscal year increased by 40.4% year-over-year, from $871K to $1.22M.
- What does lease liability payments - remainder of fiscal year mean?
- The contractual cash obligations for operating and finance leases due within the remaining months of the current fiscal year. This provides a short-term view of the company's fixed lease commitments. It is a critical component for assessing near-term liquidity and cash flow requirements.